BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 22551)

  • 1. The inhibition by 6-diazo-5-oxo-l-norleucine of glutamine catabolism of the cultured human lymphoblast.
    Willis RC; Seegmiller JE
    J Cell Physiol; 1977 Dec; 93(3):375-82. PubMed ID: 22551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inactivation of microbial glutamin-(asparagin-)ase by azaserine and 6-diazo-5-oxo-L-norleucine].
    Lebedeva ZI; Kabanova EA; Berezov TT
    Biull Eksp Biol Med; 1985 Dec; 100(12):696-8. PubMed ID: 4074870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of antitumor activity of glutamine antagonists 6-diazo-5-oxo-L-norleucine and acivicin in cell culture by glutaminase-asparaginase.
    Rosenfeld H; Roberts J
    Cancer Res; 1981 Apr; 41(4):1324-8. PubMed ID: 7214322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6-diazo-5-oxo-L-norleucine and azaserine as affinity inhibitors of glutamin(asparagin)ase.
    Lebedeva ZI; Kabanova EA; Berezov TT
    Biochem Int; 1986 Mar; 12(3):413-20. PubMed ID: 3707592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of rat renal phosphate-dependent glutaminase with 6-diazo-5-oxo-L-norleucine. Evidence for interaction at the glutamine binding site.
    Shapiro RA; Clark VM; Curthoys NP
    J Biol Chem; 1979 Apr; 254(8):2835-8. PubMed ID: 429321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral effect of 6-diazo-5-oxo-L-norleucine, antagonist of gamma-glutamyl transpeptidase, on replication of human parainfluenza virus type 2.
    Nishio M; Tsurudome M; Bando H; Komada H; Ito Y
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():61-7. PubMed ID: 1968085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of 6-diazo-5-oxo-L-norleucine and N-[N-gamma-glutamyl-6-diazo-5-oxo-norleucinyl]-6-diazo-5-oxo-norleucine against experimental tumors in conventional and nude mice.
    Ovejera AA; Houchens DP; Catane R; Sheridan MA; Muggia FM
    Cancer Res; 1979 Aug; 39(8):3220-4. PubMed ID: 572261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of glutamine in erythrocytes infected with the human malaria parasite: Plasmodium falciparum.
    Vilmont M; Azoulay M; Frappier F
    Ann Parasitol Hum Comp; 1990; 65(4):162-6. PubMed ID: 1982204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of a mutant Chinese hamster cell line resistant to the glutamine analog 6-diazo-5-oxo-L-norleucine.
    Kaufman ER
    Somat Cell Mol Genet; 1985 Jan; 11(1):1-10. PubMed ID: 3856328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 6-diazo-5-oxo-L-norleucine (DON) on human carcinoid tumor cell aggregates.
    Wu F; Bergström M; Stridsberg M; Orlefors H; Eriksson B; Oberg K; Watanabe Y; Långstrom B
    Anticancer Res; 1997; 17(4A):2363-7. PubMed ID: 9252648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutamine in the mechanism of ammonia-induced astrocyte swelling.
    Jayakumar AR; Rao KV; Murthy ChR; Norenberg MD
    Neurochem Int; 2006; 48(6-7):623-8. PubMed ID: 16517020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative effect of gamma-glutamyl transpeptidase inhibitors on metabolism of leukotriene C4 in peritoneal cells.
    Aharony D; Dobson P
    Life Sci; 1984 Nov; 35(21):2135-42. PubMed ID: 6149445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Affinity labeling of gamma-glutamyl transpeptidase and location of the gamma-glutamyl binding site on the light subunit.
    Tate SS; Meister A
    Proc Natl Acad Sci U S A; 1977 Mar; 74(3):931-5. PubMed ID: 15260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limb development in mouse embryos: protection against teratogenic effects of 6-diazo-5-ox-L-norleucine (DON) in vivo and in vitro.
    Greene RM; Kochhar DM
    J Embryol Exp Morphol; 1975 Apr; 33(2):355-70. PubMed ID: 1176851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage-mediated lysis of a beta-cell line, tumour necrosis factor-alpha release from bacillus Calmette-Guérin (BCG)-activated murine macrophages and interleukin-8 release from human monocytes are dependent on extracellular glutamine concentration and glutamine metabolism.
    Murphy C; Newsholme P
    Clin Sci (Lond); 1999 Jan; 96(1):89-97. PubMed ID: 9857111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamine metabolism in bone.
    Biltz RM; Letteri JM; Pellegrino ED; Palekar A; Pinkus LM
    Miner Electrolyte Metab; 1983; 9(3):125-31. PubMed ID: 6135980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutaminase inhibition and the release of neurotransmitter glutamate from synaptosomes.
    Bradford HF; Ward HK; Foley P
    Brain Res; 1989 Jan; 476(1):29-34. PubMed ID: 2563333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of renal gamma-glutamyl transferase by 6-diazo-5-oxo-L-norleucylglycine, an inactive precursor of affinity-labeling reagent.
    Inoue M; Morino Y
    Proc Natl Acad Sci U S A; 1981 Jan; 78(1):46-9. PubMed ID: 6113588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic mechanisms of glutamine antagonists in mouse L1210 leukemia.
    Lyons SD; Sant ME; Christopherson RI
    J Biol Chem; 1990 Jul; 265(19):11377-81. PubMed ID: 2358467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutamine as a precursor for transmitter glutamate, aspartate and GABA in the cerebellum: a role for phosphate-activated glutaminase.
    Holten AT; Gundersen V
    J Neurochem; 2008 Feb; 104(4):1032-42. PubMed ID: 17986214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.